Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kezar Life Sciences (KZR) Depreciation and Depletion (2021 - 2025)

Historic Depreciation and Depletion for Kezar Life Sciences (KZR) over the last 5 years, with Q3 2025 value amounting to $200000.0.

  • Kezar Life Sciences' Depreciation and Depletion fell 3333.33% to $200000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $900000.0, marking a year-over-year decrease of 2500.0%. This contributed to the annual value of $1.0 million for FY2024, which is 909.09% down from last year.
  • As of Q3 2025, Kezar Life Sciences' Depreciation and Depletion stood at $200000.0, which was down 3333.33% from $200000.0 recorded in Q2 2025.
  • Over the past 5 years, Kezar Life Sciences' Depreciation and Depletion peaked at $300000.0 during Q2 2021, and registered a low of $200000.0 during Q1 2021.
  • Moreover, its 5-year median value for Depreciation and Depletion was $300000.0 (2021), whereas its average is $252631.6.
  • The largest annual percentage gain for Kezar Life Sciences' Depreciation and Depletion in the last 5 years was 5000.0% (2022), contrasted with its biggest fall of 3333.33% (2022).
  • Kezar Life Sciences' Depreciation and Depletion (Quarter) stood at $200000.0 in 2021, then changed by 0.0% to $200000.0 in 2022, then skyrocketed by 50.0% to $300000.0 in 2023, then crashed by 33.33% to $200000.0 in 2024, then changed by 0.0% to $200000.0 in 2025.
  • Its Depreciation and Depletion was $200000.0 in Q3 2025, compared to $200000.0 in Q2 2025 and $300000.0 in Q1 2025.